168 related articles for article (PubMed ID: 16359350)
1. Paediatric transfusion.
New HV
Vox Sang; 2006 Jan; 90(1):1-9. PubMed ID: 16359350
[TBL] [Abstract][Full Text] [Related]
2. Practical issues in neonatal transfusion practice.
Strauss RG
Am J Clin Pathol; 1997 Apr; 107(4 Suppl 1):S57-63. PubMed ID: 9124231
[TBL] [Abstract][Full Text] [Related]
3. Platelets, frozen plasma, and cryoprecipitate: what is the clinical evidence for their use in the neonatal intensive care unit?
Poterjoy BS; Josephson CD
Semin Perinatol; 2009 Feb; 33(1):66-74. PubMed ID: 19167583
[TBL] [Abstract][Full Text] [Related]
4. Guidelines for transfusion of erythrocytes to neonates and premature infants. Fetus and Newborn Committee, Canadian Paediatric Society.
CMAJ; 1992 Dec; 147(12):1781-92. PubMed ID: 1458420
[TBL] [Abstract][Full Text] [Related]
5. Clinicians as gatekeepers: what is the best route to optimal blood use?
Isbister JP
Dev Biol (Basel); 2007; 127():9-14. PubMed ID: 17486878
[TBL] [Abstract][Full Text] [Related]
6. Blood conservation strategies in pediatric anesthesia.
Verma S; Eisses M; Richards M
Anesthesiol Clin; 2009 Jun; 27(2):337-51. PubMed ID: 19703680
[TBL] [Abstract][Full Text] [Related]
7. Assessment of safety in neonates for transfusion of platelets and plasma prepared with amotosalen photochemical pathogen inactivation treatment by a 1-month intravenous toxicity study in neonatal rats.
Ciaravino V; Hanover J; Lin L; Sullivan T; Corash L
Transfusion; 2009 May; 49(5):985-94. PubMed ID: 19175545
[TBL] [Abstract][Full Text] [Related]
8. [Indications for labile blood products].
Jeanne M; Rasonglès P
Rev Prat; 2001 Jun; 51(12):1318-27. PubMed ID: 11503505
[TBL] [Abstract][Full Text] [Related]
9. Toward rational fresh frozen plasma transfusion: The effect of plasma transfusion on coagulation test results.
Holland LL; Brooks JP
Am J Clin Pathol; 2006 Jul; 126(1):133-9. PubMed ID: 16753596
[TBL] [Abstract][Full Text] [Related]
10. Transfusion of blood components to infants under four months: review and guidelines.
O'Riordan JM; Fitzgerald J; Smith OP; Bonnar J; Gorman WA;
Ir Med J; 2007 Jun; 100(6):suppl 1-24 following 496. PubMed ID: 17668683
[No Abstract] [Full Text] [Related]
11. [Guidelines of the German Medical Association for Therapy with Blood Components and Plasma Derivatives--an introduction. Evidence-based recommendations for the risk-benefit analysis in hemotherapy].
Heim MU
Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Mar; 44(3):186-97; quiz 199. PubMed ID: 19266420
[TBL] [Abstract][Full Text] [Related]
12. Warm fresh whole blood transfusion for severe hemorrhage: U.S. military and potential civilian applications.
Spinella PC
Crit Care Med; 2008 Jul; 36(7 Suppl):S340-5. PubMed ID: 18594261
[TBL] [Abstract][Full Text] [Related]
13. Update on transfusion medicine.
Shander A; Goodnough LT
Pharmacotherapy; 2007 Sep; 27(9 Pt 2):57S-68S. PubMed ID: 17723109
[TBL] [Abstract][Full Text] [Related]
14. [Rational blood component therapy in patients with life-threatening hemorrhage].
Johansson PI; Lethagen S; Lippert FK; Stensballe J;
Ugeskr Laeger; 2005 Jun; 167(25-31):2753-5. PubMed ID: 16014258
[TBL] [Abstract][Full Text] [Related]
15. Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines.
Josephson CD; Su LL; Hillyer KL; Hillyer CD
Transfus Med Rev; 2007 Apr; 21(2):118-33. PubMed ID: 17397762
[TBL] [Abstract][Full Text] [Related]
16. [The legally required guidelines for reporting risks or side-effects caused by blood components].
Radtke H; Bachmann K; Pindur G; Koscielny J; Wenzel E; Kiesewetter H
Infusionsther Transfusionsmed; 1995 Jun; 22(3):186-95. PubMed ID: 7640512
[TBL] [Abstract][Full Text] [Related]
17. Practical guidelines for applying statistical process control to blood component production.
Beckman N; Nightingale MJ; Pamphilon D
Transfus Med; 2009 Dec; 19(6):329-39. PubMed ID: 19761545
[TBL] [Abstract][Full Text] [Related]
18. TRALI risk reduction: donor and component management strategies.
Eder AF; Benjamin RJ
J Clin Apher; 2009; 24(3):122-9. PubMed ID: 19365816
[TBL] [Abstract][Full Text] [Related]
19. Solvent-detergent plasma: use in neonatal patients, in adult and paediatric patients with liver disease and in obstetric and gynaecological emergencies.
Chekrizova V; Murphy WG
Transfus Med; 2006 Apr; 16(2):85-91. PubMed ID: 16623914
[TBL] [Abstract][Full Text] [Related]
20. Blood component therapy.
Fasano R; Luban NL
Pediatr Clin North Am; 2008 Apr; 55(2):421-45, ix. PubMed ID: 18381094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
